Shares of Galapagos NV (NASDAQ:GLPG) gapped up prior to trading on Monday . The stock had previously closed at $53.09, but opened at $53.15. Galapagos NV shares last traded at $53.51, with a volume of 19,437 shares trading hands.

Several research firms have recently weighed in on GLPG. Zacks Investment Research raised shares of Galapagos NV from a “hold” rating to a “buy” rating and set a $61.00 price target for the company in a research note on Wednesday, July 13th. Credit Suisse Group AG restated a “hold” rating and issued a $48.00 price objective on shares of Galapagos NV in a report on Friday, June 17th. Morgan Stanley restated a “buy” rating and issued a $89.00 price objective on shares of Galapagos NV in a report on Monday, May 2nd. Finally, Cowen and Company restated a “buy” rating on shares of Galapagos NV in a report on Saturday, April 30th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Galapagos NV currently has an average rating of “Buy” and an average price target of €65.50 ($72.78).

The stock has a 50 day moving average price of $54.70 and a 200-day moving average price of $48.88. The firm’s market cap is $2.46 billion.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.